BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6373920)

  • 21. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO; Morgan EL; Goodman MG; Chenoweth DE; Hugli TE
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J; Hugli TE; Smedegård G
    J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
    Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
    J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S; Ecker U; Hadding U; Bitter-Suermann D
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S; Glovsky MM; Kunkel SL
    Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE; Simpson SJ; Johnson R
    J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of chemotactic ligand receptors on human peripheral blood monocytes.
    Ohura K; Katona IM; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1987 Apr; 138(8):2633-9. PubMed ID: 2435802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological changes in human polymorphonuclear leukocytes induced by C3a in the presence and absence of cytochalasin B.
    Showell HJ; Glovsky MM; Ward PA
    Int Arch Allergy Appl Immunol; 1982; 69(1):62-7. PubMed ID: 6980842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    Huey R; Hugli TE
    J Immunol; 1985 Sep; 135(3):2063-8. PubMed ID: 4020139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human C5a des Arg increases vascular permeability.
    José PJ; Forrest MJ; Williams TJ
    J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylatoxins inhibit C2 production.
    Lappin D; Damerau B; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
    Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
    Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monokine generation as a consequence of binding of human C5a anaphylatoxin to specific cell-surface receptors.
    Goodman MG
    Lymphokine Res; 1984; 3(1):7-10. PubMed ID: 6332253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes.
    Revollo I; Nishiura H; Shibuya Y; Oda Y; Nishino N; Yamamoto T
    Inflamm Res; 2005 Feb; 54(2):82-90. PubMed ID: 15750715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo.
    DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P
    J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.